Literature DB >> 34232742

A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.

Nicholas J Lennemann1, Jacob Dillard1, Natalie Ruggio1, Ashley L Cooney1, Grace A Schaack1, Robert A Davey2, Wendy Maury1.   

Abstract

Sudan virus (SUDV) is one of five filoviruses that compose the genus Ebolavirus that has been responsible for episodic outbreaks in Central Africa. While the SUDV glycoprotein (GP) structure has been solved, GP residues that affect SUDV entry have not been extensively examined; many of the entry characteristics of SUDV GP are inferred from studies with the Zaire Ebola virus (EBOV) GP. Here, we investigate the effect on virus entry of a naturally occurring polymorphism in SUDV GP. Two of the earliest SUDV isolates contain glutamine at residue 95 (Q95) within the base region of GP1, whereas more recent SUDV isolates and GPs from all other ebolaviruses carry lysine at this position (K95). A K95Q change dramatically decreased titers of pseudovirions bearing SUDV GP, whereas the K95Q substitution in EBOV GP had no effect on titer. We evaluated virus entry to identify SUDV GP Q95-specific entry defects. The presence of Q95 in either EBOV or SUDV GP resulted in enhanced sensitivity of GP to proteolytic processing, yet this could not account for the SUDV-specific decrease in GP Q95 infectivity. We found that SUDV GP Q95 pseudovirions were more sensitive to imipramine, a GP-destabilizing antiviral. In contrast, SUDV GP K95 was more stable, requiring elevated temperatures to inhibit virus infection. Thus, the residue present at GP 95 has a critical role in stabilizing the SUDV glycoprotein, whereas this polymorphism has no effect on EBOV GP stability. These results provide novel insights into filovirus species-specific GP structure that affects virus infectivity. IMPORTANCE Filovirus outbreaks are associated with significant morbidity and mortality. Understanding the structural constraints of filoviral GPs that control virus entry into cells is critical for rational development of novel antivirals to block infection. Here, we identify a naturally occurring glutamine (Q) to lysine (K) polymorphism at residue 95 as a critical determinant of Sudan virus GP stability but not Zaire Ebola virus GP stability. We propose that glutamine at residue 95 in Sudan virus GP mediates decreased virus entry, thereby reducing infectivity. Our findings highlight a unique structural characteristic of Sudan virus GP that affects GP-mediated functionality. Further, it provides a cautionary note for the development of future broad-spectrum filovirus antivirals.

Entities:  

Keywords:  Ebola virus; Sudan virus; filovirus; genetic polymorphisms; polymorphism; protein stability; viral glycoprotein; virus entry

Mesh:

Substances:

Year:  2021        PMID: 34232742      PMCID: PMC8387054          DOI: 10.1128/JVI.01073-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Effects of hemagglutinin amino acid substitutions in H9 influenza A virus escape mutants.

Authors:  Irina A Rudneva; Tatiana A Timofeeva; Anna V Ignatieva; Aleksandr A Shilov; Natalia A Ilyushina
Journal:  Arch Virol       Date:  2016-09-01       Impact factor: 2.574

2.  Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.

Authors:  Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Katie A Howell; Sonal J Patel; Bronwyn Gunn; Marcus Karim; Jonathan R Lai; Julia C Frei; Elisabeth K Nyakatura; Larry Zeitlin; Robin Douglas; Marnie L Fusco; Jeffrey W Froude; Erica Ollmann Saphire; Andrew S Herbert; Ariel S Wirchnianski; Calli M Lear-Rooney; Galit Alter; John M Dye; Pamela J Glass; Kelly L Warfield; M Javad Aman
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

3.  Ebola virus entry requires the host-programmed recognition of an intracellular receptor.

Authors:  Emily Happy Miller; Gregor Obernosterer; Matthijs Raaben; Andrew S Herbert; Maika S Deffieu; Anuja Krishnan; Esther Ndungo; Rohini G Sandesara; Jan E Carette; Ana I Kuehne; Gordon Ruthel; Suzanne R Pfeffer; John M Dye; Sean P Whelan; Thijn R Brummelkamp; Kartik Chandran
Journal:  EMBO J       Date:  2012-03-06       Impact factor: 11.598

4.  Covalent modifications of the ebola virus glycoprotein.

Authors:  Scott A Jeffers; David Avram Sanders; Anthony Sanchez
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.

Authors:  Chantelle L Hood; Jonathan Abraham; Jeffrey C Boyington; Kwanyee Leung; Peter D Kwong; Gary J Nabel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

6.  Membrane fusion activity of vesicular stomatitis virus glycoprotein G is induced by low pH but not by heat or denaturant.

Authors:  Yi Yao; Kakoli Ghosh; Raquel F Epand; Richard M Epand; Hara P Ghosh
Journal:  Virology       Date:  2003-06-05       Impact factor: 3.616

7.  Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.

Authors:  Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Tom Larsen; Elliott Kagan; Lisa E Hensley
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry.

Authors:  Ayato Takada; Kouki Fujioka; Makoto Tsuiji; Akiko Morikawa; Nobuaki Higashi; Hideki Ebihara; Darwyn Kobasa; Heinz Feldmann; Tatsuro Irimura; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Toremifene interacts with and destabilizes the Ebola virus glycoprotein.

Authors:  Yuguang Zhao; Jingshan Ren; Karl Harlos; Daniel M Jones; Antra Zeltina; Thomas A Bowden; Sergi Padilla-Parra; Elizabeth E Fry; David I Stuart
Journal:  Nature       Date:  2016-06-29       Impact factor: 49.962

10.  IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection.

Authors:  Kai J Rogers; Bethany Brunton; Laura Mallinger; Dana Bohan; Kristina M Sevcik; Jing Chen; Natalie Ruggio; Wendy Maury
Journal:  PLoS Negl Trop Dis       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.